Smruthi Organics Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Smruthi Organics Ltd is ₹ 115.75 as of 18 May 15:30 . The P/E Ratio of Smruthi Organics Ltd changed from 14.9 on March 2021 to 35.5 on March 2025 . This represents a CAGR of 18.96% over 5 yearsThe P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Smruthi Organics Ltd changed from ₹ 254.45 crore on March 2021 to ₹ 126.2 crore on March 2025 . This represents a CAGR of -13.09% over 5 yearsThe Market Cap of Vista Pharmaceuticals Ltd changed from ₹ 33.26 crore on March 2021 to ₹ 39.52 crore on March 2025 . This represents a CAGR of 3.51% over 5 years The revenue of Smruthi Organics Ltd for the Mar '26 is ₹ 29.11 crore as compare to the Dec '25 revenue of ₹ 22.3 crore. This represent the growth of 30.54% The revenue of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 2.51 crore. This represent the decline of -100% The ebitda of Smruthi Organics Ltd for the Mar '26 is ₹ 3.8 crore as compare to the Dec '25 ebitda of ₹ 3.56 crore. This represent the growth of 6.74% The ebitda of Vista Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -2.92 crore. This represent the decline of -100% The net profit of Smruthi Organics Ltd changed from ₹ -0.92 crore to ₹ 1.07 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Vista Pharmaceuticals Ltd changed from ₹ -0.86 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Smruthi Organics Ltd changed from 20.08 % on March 2021 to 48.24 % on March 2025 . This represents a CAGR of 19.16% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Smruthi Organics Ltd

Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
The Company was promoted by E Purushotham and Shankarrao R Myakal.
The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

FAQs for the comparison of Smruthi Organics Ltd and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Smruthi Organics Ltd or Vista Pharmaceuticals Ltd?

Market cap of Smruthi Organics Ltd is 132 Cr while Market cap of Vista Pharmaceuticals Ltd is 44 Cr

What are the key factors driving the stock performance of Smruthi Organics Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Smruthi Organics Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Smruthi Organics Ltd and Vista Pharmaceuticals Ltd?

As of May 18, 2026, the Smruthi Organics Ltd stock price is INR ₹115.75. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹7.26.

How do dividend payouts of Smruthi Organics Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Smruthi Organics Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.